Results
| PMID | 25228630 |
| Gene Name | TDGF1 |
| Condition | Endometriosis |
| Association |
Associated |
| Population size | 27 |
| Population details | 27 (15 women with endometriosis, 15 women without endometriosis) |
| Age | 22- 43 yrs |
| Sex | Female |
| Associated genes | Nodal, Cripto, SMAD3, SMAD4 |
| Other associated phenotypes |
Endometriosis |
|
Reprod Sci. 2015 May;22(5):527-33. doi: 10.1177/1933719114549855. Epub 2014 Sep Cruz, Cynthia Dela| Del Puerto, Helen L| Rocha, Ana Luiza L| Cavallo, Ines K| Clarizia, Alessandra D| Petraglia, Felice| Reis, Fernando M Division of Human Reproduction, Department of Obstetrics and Gynecology, Federal University of Minas Gerais, Belo Horizonte, Brazil.| Division of Human Reproduction, Department of Obstetrics and Gynecology, Federal University of Minas Gerais, Belo Ho BACKGROUND: Nodal is a growth factor of the transforming growth factor beta superfamily that is expressed in high turnover tissues, such as the human endometrium, and in several malignancies. The effects of Nodal are modulated by the coreceptor Cripto and mediated by SMAD proteins. This study evaluated the gene and protein expression of Nodal, Cripto, total and phosphorylated (p) SMAD3, and SMAD4 in the proliferative endometrium of women with and without endometriosis. METHOD: Total RNA was isolated and complementary DNA synthesized from eutopic endometrium of women with (n = 15) and without (n = 12) endometriosis, followed by quantitative real-time polymerase chain reaction (PCR) to evaluate the gene expression of Nodal, Cripto, SMAD3, and SMAD4. Western blot was used to evaluate the protein levels of Nodal and Cripto, and immunohistochemistry was performed to localize SMAD3, pSMAD3, and SMAD4. RESULTS: Although Nodal expression was unchanged in women with endometriosis, real-time PCR indicated lower gene expression of Cripto (fold change 0.27, P < .05) in the endometriosis group. This difference, however, was not maintained at protein expression level as assessed by Western blot. The immunostaining of total SMAD3 was reduced in the endometriosis group (P < .01), but the localization of pSMAD3 and the nuclear staining of SMAD4 were unchanged. CONCLUSION: These findings suggest that the Nodal signaling pathway has subtle changes in the endometrium of women with endometriosis, but this imbalance may not cause functional damage as it seems not to affect the nuclear expression of SMAD4. Mesh Terms: Adult| Blotting, Western| Case-Control Studies| *Cell Proliferation| Endometriosis/diagnosis/genetics/*metabolism| Endometrium/*chemistry/pathology| Female| GPI-Linked Proteins/*analysis/genetics| Gene Expression Regulation| Humans| Immunohistoc |
|